| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/11/2010 | US20100286024 Insulinotropic compounds and uses thereof |
| 11/11/2010 | US20100286023 Compositions and Methods for Increasing Muscle Mass, Strength, and Functional Performance in the Elderly |
| 11/11/2010 | US20100286022 Edible and biocompatible metal-organic frameworks |
| 11/11/2010 | US20100285529 Feline granulocyte macrophage colony stimulating factor proteins |
| 11/11/2010 | US20100285448 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 11/11/2010 | US20100285159 Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals |
| 11/11/2010 | US20100285157 Granules, tablets and method of producing the same |
| 11/11/2010 | US20100285155 Cleanser composition and methods for using the same |
| 11/11/2010 | US20100285154 Use of lignan compounds for treating or preventing inflammatory disease |
| 11/11/2010 | US20100285149 Novel tetrahydropyridothiophenes |
| 11/11/2010 | US20100285148 Oral care method and kit |
| 11/11/2010 | US20100285145 Gpr 119 modulators |
| 11/11/2010 | US20100285144 Polymer-epothilone conjugates, particles, compositions, and related methods of use |
| 11/11/2010 | US20100285142 Method Of Making Particles For Use In A Pharmaceutical Composition |
| 11/11/2010 | US20100285141 Compositions and methods for enhancing the activity of podophyllotoxin |
| 11/11/2010 | US20100285139 Pharmaceutical composition for the prophylaxis and/or symptomatic treatment of cystic fibrosis |
| 11/11/2010 | US20100285138 Compositions comprising nanoparticles and apoptotic agents and methods of use |
| 11/11/2010 | US20100285134 Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases |
| 11/11/2010 | US20100285133 Transdermal drug delivery system containing granisetron |
| 11/11/2010 | US20100285130 Coating of complexed actives in film formulations |
| 11/11/2010 | US20100285127 Taste masked pharmaceutical compositions of s-alkylisothiouronium derivatives |
| 11/11/2010 | US20100285126 Pharmaceutical compositions of fenofibrate |
| 11/11/2010 | US20100285125 Delivery system for poorly soluble drugs |
| 11/11/2010 | US20100285124 Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological |
| 11/11/2010 | US20100285123 Controlled Release Dosage Formulation of Duloxetine |
| 11/11/2010 | US20100285122 Tablets for combination therapy |
| 11/11/2010 | US20100285121 Capsule Formulation |
| 11/11/2010 | US20100285120 Controlled release preparation |
| 11/11/2010 | US20100285119 Multiparticulate Extended Release Pharmaceutical Composition Of Carbamazepine And Process For Manufacturing The Same |
| 11/11/2010 | US20100285118 Encapsulated omega-3 fatty acids and/or omega-6 fatty acids and/or esters thereof with a coating |
| 11/11/2010 | US20100285117 Combination of triazine derivatives and insulin sensitisers |
| 11/11/2010 | US20100285116 Physically/molecularly distributed and/or chemically bound medicaments in empty, hard capsule shells |
| 11/11/2010 | US20100285115 Novel Antiretroviral Combination |
| 11/11/2010 | US20100285114 Pharmaceutical compositions of rhein or diacerein |
| 11/11/2010 | US20100285113 Enhanced stability of inverse thermal gelling composite hydrogels |
| 11/11/2010 | US20100285112 Methods of delivering oligonucleotides to immune cells |
| 11/11/2010 | US20100285111 Self-assembling micelle-like nanoparticles for systemic gene delivery |
| 11/11/2010 | US20100285110 Composition comprising mucilaginous polysaccharides derived from aloe barbadensis combined with liposomes, method for obtaining same and use thereof as a sun protector, an anti-acne agent, an epidermal regenerator and a moisturiser |
| 11/11/2010 | US20100285109 Truncated secretory aspartyl proteinase 2 |
| 11/11/2010 | US20100285107 Short nucleic acid molecule-mediated modulation of aurora b kinase expression and combinations for use in anticancer therapy |
| 11/11/2010 | US20100285097 Vaginal delivery system |
| 11/11/2010 | US20100285096 Hygiene Article Having Calcium Sugar Phosphate |
| 11/11/2010 | US20100285095 Hygiene Article Having Calcium Sugar Acid Salt |
| 11/11/2010 | US20100285089 Medical Devices, Drug Coatings And Methods For Maintaining The Drug Coatings Thereon |
| 11/11/2010 | US20100285087 Single phenothiazine enantiomers as agents for the prevention of bone loss |
| 11/11/2010 | US20100285085 Balloon coating with drug transfer control via coating thickness |
| 11/11/2010 | US20100285083 Drug delivery system |
| 11/11/2010 | US20100285078 Alloplastic injectable dermal filler and methods of use thereof |
| 11/11/2010 | US20100285075 Novel Hemioxalate Salt of Eletriptan |
| 11/11/2010 | US20100285074 Phenoxyalkylcarboxylic acid derivatives in the treatment of irritable bowel syndrome |
| 11/11/2010 | US20100285073 a micro-rna family that modulates fibrosis and uses thereof |
| 11/11/2010 | US20100285064 Adjuvant composition for vaccine |
| 11/11/2010 | US20100285052 Chemically Programmable Immunity |
| 11/11/2010 | US20100285049 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 11/11/2010 | US20100285046 Nontoxic ricin mutant compositions and methods |
| 11/11/2010 | US20100285045 Novel Neurotrophic Factor Protein and Uses Thereof |
| 11/11/2010 | US20100285044 Method and compositions for treatment of cancers |
| 11/11/2010 | US20100285040 Methods of enhancing immune response using electroporation-assisted vaccination and boosting |
| 11/11/2010 | US20100285038 Factor Involved in Metastasis and Uses Thereof |
| 11/11/2010 | US20100285032 Estrogen receptor-related receptor gamma (err gamma) in bone and cartilage formation and methods and compositions relating to same |
| 11/11/2010 | US20100285031 Hox Compositions and Methods |
| 11/11/2010 | US20100285030 Antibodies to Ox-2/Cd200 and Uses Thereof |
| 11/11/2010 | US20100285029 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti-hsp90 antibodies |
| 11/11/2010 | US20100285028 Methods of treating coagulopathy |
| 11/11/2010 | US20100285024 Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases |
| 11/11/2010 | US20100285023 Detecting cyp24 expression level as a marker for predisposition to cancer |
| 11/11/2010 | US20100285020 Leukemic cell cns infiltration controlled by notch-induced chemotaxis |
| 11/11/2010 | US20100285012 Methods and compositions for the treatment of cancers and pathogenic infections |
| 11/11/2010 | US20100285008 Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis |
| 11/11/2010 | US20100285006 Compositions of Kinase Inhibitors and Their Use for Treatment of Cancer and Other Diseases Related to Kinases |
| 11/11/2010 | US20100285002 Treatment or prevention of inflammation by targeting cyclin d1 |
| 11/11/2010 | US20100285001 Method and Compositions Related to Synergistic Responses to Oncogenic Mutations |
| 11/11/2010 | US20100284994 Use of edta and its derivatives for prevention and treatment of bacterial intestinal diseases of pigs and for increasing the effects of antibiotics exerted in such diseases |
| 11/11/2010 | US20100284993 Enhancing the Efficacy of Anti-Infective Therapeutics |
| 11/11/2010 | US20100284991 Methods for the Treatment and Diagnosis of Bone Mineral Density Related Diseases |
| 11/11/2010 | US20100284989 15-pgdh in colon cancer |
| 11/11/2010 | US20100284987 Tablettable formulations of lipophilic health ingredients |
| 11/11/2010 | US20100284984 Adenosine and its mimetics. modulators, transport inhibitors, and receptor agonists as a therapeutic tool to replace or improve the efficacy of deep brain stimulation |
| 11/11/2010 | US20100284983 Coenzyme q10-containing water-soluble composition and process for production thereof |
| 11/11/2010 | US20100284975 Polypeptides comprising fas activation and nkg2d-ligand domains |
| 11/11/2010 | US20100284972 Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans |
| 11/11/2010 | US20100284971 Modified factor viii and factor ix genes and vectors for gene therapy |
| 11/11/2010 | US20100284970 Benzimidazole modulators of h1 receptor and/or ns4b protein |
| 11/11/2010 | US20100284964 Cancer therapy |
| 11/11/2010 | US20100284961 MCP-1 binding nucleic acids |
| 11/11/2010 | US20100284960 Dosage Forms and Co-Administration of Opioid Agonist and Opioid Antagonist |
| 11/11/2010 | US20100284959 Sequence specific double-stranded dna/rna binding compounds and uses thereof |
| 11/11/2010 | US20100284958 BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin Therapy |
| 11/11/2010 | US20100284945 Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy |
| 11/11/2010 | US20100284944 Off-note blocking sensory organic compounds |
| 11/11/2010 | US20100284942 Compositions |
| 11/11/2010 | US20100284940 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
| 11/11/2010 | US20100284938 Penetrating pharmaceutical foam |
| 11/11/2010 | US20100284937 Vaginal lubricant comprising hyaluronic acid |
| 11/11/2010 | US20100284925 Small Molecule Intervention for Obesity |
| 11/11/2010 | US20100284916 Antibodies Against Human Cytomegalovirus (HCMV) |
| 11/11/2010 | US20100284915 Genes associated with chemotherapy response and uses thereof |
| 11/11/2010 | US20100284914 Novel Amine-Borane Compounds and Uses Thereof |
| 11/11/2010 | US20100284913 Methods and compositions for studying, imaging, and treating pain |
| 11/11/2010 | US20100284907 Treatment of tumors by ablating bone marrow-derived endothelial progenitor cells |